lamivudine

FDA Drug Profile — LAMIVUDINE, EPIVIR, lamivudine

Drug Details

Generic Name
lamivudine
Brand Names
LAMIVUDINE, EPIVIR, lamivudine
Application Number
ANDA091606
Sponsor
Glaxo Wellcome Manufacturing Pte. Ltd
NDC Codes
11
Dosage Forms
POWDER, TABLET, FILM COATED, SOLUTION
Routes
ORAL
Active Ingredients
LAMIVUDINE

Indications and Usage

1 INDICATIONS & USAGE Lamivudine and zidovudine tablets a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogue reverse transcriptase inibitors, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. (1)